View in EDS

Analytical Validation of Blood-Derived Tumor Mutation Burden (bTMB) Assays: A Joint Consensus Recommendation of the BLOODPAC bTMB Analytical Validation Working Group.

Saved in:
Bibliographic Details
Title: Analytical Validation of Blood-Derived Tumor Mutation Burden (bTMB) Assays: A Joint Consensus Recommendation of the BLOODPAC bTMB Analytical Validation Working Group.
Authors: Baden J; Bristol Myers Squibb, Lawrence Township, New Jersey., Sausen M; Labcorp, Baltimore, Maryland., Anfora AT; LGC Clinical Diagnostics, Milford, Massachusetts., D'Auria KM; Guardant Health, Palo Alto, California., Dickey J; Labcorp, Baltimore, Maryland., Godsey JH; Quest Diagnostics, Secaucus, New Jersey., Guan L; Illumina, San Diego, California., Lococo JS; Illumina, San Diego, California., Mansfield E; Foundation Medicine, Boston, Massachusetts., Meier KL; Illumina, San Diego, California., Merriam D; LGC Clinical Diagnostics, Milford, Massachusetts., Pawloski T; Illumina, San Diego, California., Shukla S; Guardant Health, Palo Alto, California., Stetson D; AstraZeneca, Wilmington, Delaware., Stewart MD; Friends of Cancer Research, Washington, District of Columbia., Wenz P; Illumina, San Diego, California., Leiman LC; BLOODPAC, Chicago, Illinois. Electronic address: lauren@bloodpac.org.
Source: The Journal of molecular diagnostics : JMD [J Mol Diagn] 2025 Oct; Vol. 27 (10), pp. 914-919.
Publication Type: Journal Article; Review; Consensus Statement
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100893612 Publication Model: Print Cited Medium: Internet ISSN: 1943-7811 (Electronic) Linking ISSN: 15251578 NLM ISO Abbreviation: J Mol Diagn Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1943-7811
DOI:10.1016/j.jmoldx.2025.06.008